Eli Lilly and Company (LLY)
Working capital turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 34,124,100 | 32,072,500 | 29,515,500 | 27,691,400 | 28,541,400 | 29,239,500 | 29,070,700 | 29,322,800 | 28,318,400 | 27,758,500 | 26,726,300 | 25,485,600 | 24,539,800 | 23,213,800 | 22,949,800 | 23,087,100 | 22,319,500 | 21,843,100 | 21,673,400 | 21,621,700 |
Total current assets | US$ in thousands | 25,727,000 | 23,007,000 | 21,331,600 | 20,811,400 | 18,034,500 | 17,639,900 | 17,115,200 | 16,964,700 | 18,452,400 | 17,808,300 | 17,295,500 | 16,604,500 | 17,462,100 | 16,239,900 | 14,581,900 | 13,994,200 | 13,709,600 | 12,661,800 | 13,454,500 | 12,597,500 |
Total current liabilities | US$ in thousands | 27,293,200 | 21,998,200 | 18,915,000 | 16,010,000 | 17,138,200 | 15,652,800 | 15,620,600 | 13,386,000 | 15,052,700 | 13,682,000 | 15,093,200 | 11,714,200 | 12,481,600 | 11,976,900 | 11,988,500 | 12,610,200 | 11,775,200 | 10,828,600 | 11,855,400 | 11,236,100 |
Working capital turnover | — | 31.79 | 12.21 | 5.77 | 31.84 | 14.71 | 19.45 | 8.19 | 8.33 | 6.73 | 12.14 | 5.21 | 4.93 | 5.45 | 8.85 | 16.68 | 11.54 | 11.92 | 13.55 | 15.88 |
December 31, 2023 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $34,124,100K ÷ ($25,727,000K – $27,293,200K)
= —
The working capital turnover ratio measures how efficiently a company is using its working capital to generate sales revenue. A higher ratio indicates better efficiency in managing working capital.
For Lilly(Eli) & Co, the working capital turnover ratio showed fluctuations throughout the quarters in 2022 and 2023. In Q4 2023, the ratio was not provided, but in Q3 2023, it was 31.79, indicating a significant improvement in efficiency compared to Q2 2023 (12.21) and Q1 2023 (5.77). This may suggest that the company effectively utilized its working capital to generate sales in Q3 2023.
Looking back at 2022, the working capital turnover ratio was quite variable, ranging from 8.19 in Q1 to 31.84 in Q4. The highest ratio was seen in Q4, indicating a strong efficiency in using working capital to drive sales. Q2 2022 (19.45) also showed a relatively good performance in this aspect.
Overall, Lilly(Eli) & Co's working capital turnover ratio has displayed fluctuations over the periods analyzed. It is essential for the company to maintain a balance in managing its working capital efficiently to ensure sustainable operational performance and profitability.
Peer comparison
Dec 31, 2023
See also:
Eli Lilly and Company Working Capital Turnover (Quarterly Data)